3. Patients’ accrual and characteristics.
| Cases | Diagnosis | Age (year) | Histology/site of disease |
| DL, dose level; ADC, adenocarcinoma; SCC, squamous cell carcinoma; PAN, para aortic lymph node; EMC, endometrial cancer. | |||
| DL1-1 | Cervical recurrence | 49 | 1b/ADC |
| DL1-2 | Cervical IVA | 73 | SCC |
| DL1-3 | Cervical IIB | 55 | SCC |
| DL2-1 | Cervical IIIB | 67 | ADC/T3N1M0 |
| DL2-2 | Cervical IIIB | 58 | SCC |
| DL2-3 | Cervical IIIB | 55 | SCC |
| DL2-4 | Cervical recurrence | 52 | ADC/pT2bNR1M0, stump recurrence |
| DL2-5 | Cervical recurrence | 46 | SCC/pT2bNR1M0, PAN metastasis |
| DL3-1 | Cervical IIIB | 61 | ADC+SCC |
| DL3-2 | Cervical recurrence | 69 | SCC/lumber bone metastasis |
| DL3-3 | Cervical IB2 | 69 | ADC |
| DL3-4 | Corpus recurrence | 57 | EMC, G3, PAN |
| DL3-5 | Cervical IVB | 50 | SCC, PAN |
| DL3-6 | Cervical recurrence | 74 | SCC, PAN |
| DL4-1 | Cervical recurrence | 63 | SCC, PAN |
| DL4-2 | Cervical IIIB | 46 | ADC, mucinous type |
| DL4-3 | Cervical IIB | 72 | SCC |